RxDoctor Payments Data

John Proctor, MD

Family Medicine · Cincinnati, OHNPI 1407376239

Payments from drug & device makers

$3,961in general payments, 2019–2025

Across 222 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$841
  • Novo Nordisk$638
  • Lilly USA, LLC$283
  • Pfizer$188
  • Otsuka America Pharmaceutical, Inc.$150
  • GSK$142
  • plus $2K from 35 others

What the payments were for

  • Food & beverage$3,961100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,961 in reported general payments places this provider in the 80th percentile of 3,983 family medicine providers in Ohio.

See all family medicine providers in Ohio

Medicare billing

Part B allowed, 2024
$43,672
Medicare patients
227
Services billed
484

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide13$26,492
EliquisApixaban24$22,746
OzempicSemaglutide15$21,877
FarxigaDapagliflozin Propanediol13$18,587
JanuviaSitagliptin Phosphate22$17,874
MounjaroTirzepatide12$17,515
JardianceEmpagliflozin18$16,735
Atorvastatin Calcium230$2,044
Ultra-Fine Mini Pen NeedlePen Needle, Diabetic18$1,420
Albuterol Sulfate HfaAlbuterol Sulfate68$1,348
Metoprolol Succinate78$1,087
Levothyroxine Sodium88$1,003
Duloxetine Hcl30$973
Amlodipine Besylate152$793
Lisinopril106$698

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$283$44,00725 claims
PfizerEliquis$188$22,74624 claims
Novo NordiskOzempic$638$21,87715 claims
AstraZenecaFarxiga$39$18,58713 claims
MerckJanuvia$67$17,87422 claims
Boehringer IngelheimJardiance$126$16,73518 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,983 family medicine providers in Ohio.

Other family medicine in Cincinnati

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →